BQLCX | VITSX | BQLCX / VITSX | |
Total Expense Ratio | 0.89 | 0.03 | 2,967% |
Annual Report Gross Expense Ratio | 0.89 | 0.03 | 2,967% |
Fund Existence | 15 years | 28 years | - |
Gain YTD | 4.707 | 6.423 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 412M | 1.82T | 0% |
Annual Yield % from dividends | 0.66 | 1.22 | 54% |
Returns for 1 year | 1.40 | 13.90 | 10% |
Returns for 3 years | 20.35 | 62.12 | 33% |
Returns for 5 years | 39.35 | 95.64 | 41% |
Returns for 10 years | 75.04 | 198.64 | 38% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SCO | 17.36 | 0.11 | +0.64% |
ProShares UltraShort Bloomberg Crude Oil | |||
BBP | 59.73 | 0.31 | +0.51% |
Virtus LifeSci Biotech Products ETF | |||
QMAR | 31.07 | 0.12 | +0.39% |
FT Vest Nasdaq-100 Buffer ETF – Mar | |||
IBDR | 24.17 | 0.02 | +0.08% |
iShares iBonds Dec 2026 Term Corp ETF | |||
LFAL | 137.99 | N/A | N/A |
LifeX 2053 Longevity Income ETF |